Bainan Biotech ApS

Bainan Biotech ApS is a preclinical life science company developing a therapeutic to treat osteoporosis. The company’s GIPR/GLP-2R dual agonist is a first-in-class therapy that leverages on the effects of intestinal hormones to strengthen bones.

Contact name:

Tue Emborg, CEO

Address:

Ole Maaløes Vej 3, 3rd floor, 2200 Kbh N, Denmark

Telephone:

+45 28936889

Established:

2018

Number of employees:

6

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2020 Danskbiotek. All rights reserved.